Luisa M. Solis

7.3k total citations · 1 hit paper
68 papers, 2.9k citations indexed

About

Luisa M. Solis is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luisa M. Solis has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 32 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luisa M. Solis's work include Lung Cancer Treatments and Mutations (14 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Luisa M. Solis is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Luisa M. Solis collaborates with scholars based in United States, Chile and Netherlands. Luisa M. Solis's co-authors include Ignacio I. Wistuba, Carmen Behrens, John D. Minna, César A. Moran, J. Jack Lee, Humam Kadara, Stephen G. Swisher, Rossana Lazcano, Wenli Dong and Alejandro H. Corvalán and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Luisa M. Solis

67 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanical regulation of glycolysis via cytoskeleton architecture

2020 396 citations Luisa M. Solis, John D. Minna et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa M. Solis United States	28	1.8k	831	662	594	306	68	2.9k
Kaustubh Datta United States	33	2.0k 1.2×	827 1.0×	787 1.2×	447 0.8×	350 1.1×	75	3.1k
Parthasarathy Seshacharyulu United States	29	1.7k 1.0×	1.1k 1.3×	595 0.9×	421 0.7×	435 1.4×	53	2.9k
Geoffrey Bartholomeusz United States	24	2.0k 1.2×	1.1k 1.3×	482 0.7×	542 0.9×	231 0.8×	45	3.1k
Jan Bouchal Czechia	27	1.5k 0.9×	939 1.1×	613 0.9×	449 0.8×	204 0.7×	86	2.6k
Zhenhe Suo Norway	32	1.8k 1.0×	1.3k 1.5×	872 1.3×	447 0.8×	273 0.9×	107	3.1k
Kristiina Iljin Finland	30	2.1k 1.2×	767 0.9×	763 1.2×	594 1.0×	197 0.6×	56	3.1k
Chih‐Yang Wang Taiwan	32	2.3k 1.3×	1.1k 1.3×	1.1k 1.7×	672 1.1×	408 1.3×	108	3.6k
Ievgenia Pastushenko Belgium	10	1.6k 0.9×	1.2k 1.4×	973 1.5×	349 0.6×	271 0.9×	16	2.7k
Go J. Yoshida Japan	21	1.5k 0.8×	931 1.1×	949 1.4×	313 0.5×	248 0.8×	25	2.5k
François Lamoureux France	31	1.6k 0.9×	830 1.0×	567 0.9×	717 1.2×	216 0.7×	73	2.5k

Countries citing papers authored by Luisa M. Solis

Since Specialization

Citations

This map shows the geographic impact of Luisa M. Solis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa M. Solis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa M. Solis more than expected).

Fields of papers citing papers by Luisa M. Solis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa M. Solis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa M. Solis. The network helps show where Luisa M. Solis may publish in the future.

Co-authorship network of co-authors of Luisa M. Solis

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa M. Solis. A scholar is included among the top collaborators of Luisa M. Solis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa M. Solis. Luisa M. Solis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parra, Edwin R., Jiexin Zhang, Mei Jiang, et al.. (2023). Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer. Nature Communications. 14(1). 2364–2364. 22 indexed citations

Marques‐Piubelli, Mario L., Do H. Kim, L. Jeffrey Medeiros, et al.. (2023). CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy. Histopathology. 83(1). 143–148. 10 indexed citations

Deng, Nan, Laura Reyes-Uribe, Edwin R. Parra, et al.. (2023). Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. Frontiers in Immunology. 14. 1162669–1162669. 3 indexed citations

Romain, Gabrielle, Paolo Strati, Ali Rezvan, et al.. (2022). Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. Journal of Clinical Investigation. 132(17). 36 indexed citations

Marques‐Piubelli, Mario L., Xiaoqiong Wang, Tiffany G. Sheu, et al.. (2022). CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(4). 659–663. 4 indexed citations

Jiao, Jingjing, Ómar A. Saldarriaga, Luisa M. Solis, et al.. (2022). Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. JHEP Reports. 5(2). 100628–100628. 31 indexed citations

Kasiri, Sahba, Baozhi Chen, Barbara Mino, et al.. (2020). Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species. Oncogene. 39(16). 3258–3275. 18 indexed citations

Zheng, Lin, Zibo Chen, Masanori Kawakami, et al.. (2019). Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. Molecular Cancer Therapeutics. 18(10). 1775–1786. 27 indexed citations

Kabbout, Mohamed, Melinda Garcia, Junya Fujimoto, et al.. (2013). ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 19(13). 3383–3395. 116 indexed citations

10.

Gold, Kathryn A., Edward S. Kim, Diane D. Liu, et al.. (2013). Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy. Clinical Cancer Research. 20(7). 1946–1954. 27 indexed citations

11.

Behrens, Carmen, Luisa M. Solis, Heather Lin, et al.. (2013). EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clinical Cancer Research. 19(23). 6556–6565. 123 indexed citations

12.

Chang, Xiaofei, Eugene Izumchenko, Luisa M. Solis, et al.. (2013). The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors. PLoS ONE. 8(7). e68966–e68966. 25 indexed citations

13.

Long, Weiwen, Charles E. Foulds, Jun Qin, et al.. (2012). ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. Journal of Clinical Investigation. 122(5). 1869–1880. 98 indexed citations

14.

Xie, Yang, Guanghua Xiao, Kevin R. Coombes, et al.. (2011). Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients. Clinical Cancer Research. 17(17). 5705–5714. 130 indexed citations

15.

Solis, Luisa M., Carmen Behrens, Maria Gabriela Raso, et al.. (2011). Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 118(11). 2889–2899. 85 indexed citations

16.

Kadara, Humam, Carmen Behrens, Ping Yuan, et al.. (2010). A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis. Clinical Cancer Research. 17(6). 1490–1501. 68 indexed citations

17.

Banyard, Jacqueline, Luisa M. Solis, Ignacio I. Wistuba, et al.. (2010). Collagen XXIII: A Potential Biomarker for the Detection of Primary and Recurrent Non–Small Cell Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(5). 1362–1372. 29 indexed citations

18.

Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations

19.

Ooi, Aik T., Vei Mah, Derek W. Nickerson, et al.. (2010). Presence of a Putative Tumor-Initiating Progenitor Cell Population Predicts Poor Prognosis in Smokers with Non–Small Cell Lung Cancer. Cancer Research. 70(16). 6639–6648. 47 indexed citations

20.

Kadara, Humam, Ludovic Lacroix, Carmen Behrens, et al.. (2009). Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System. Cancer Prevention Research. 2(8). 702–711. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact